Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Follows adults with asthma in China over time to track outcomes

Follows people with asthma in China to study how the disease progresses and find markers.

Plain-language title generated from the registry record
Registry title: The Cohort Study for Asthma in China

Key facts

Where
Beijing, ChinaSee the site

Where in China

  • Beijing Chao-Yang HospitalBeijing, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Beijing Chao Yang Hospital
Trial code
NCT05937334
Record updated
10 July 2023
Original description
The study is to establish a standardized asthma cohort study, build an information network platform system and a biospecimen bank for asthma cohort, establish clear follow-up standards and norms, observe the asthma outcomes and identify biomarkers to predict asthma outcomes.Read full original descriptionShow less

The Cohort Study for Asthma in China: an Prospective Observational Study

The study is to establish a standardized asthma cohort study, build an information network platform system and a biospecimen bank for asthma cohort, establish clear follow-up standards and norms, observe the asthma outcomes and identify biomarkers to predict asthma outcomes.

Inclusion: Age >18; Meet the 2023 edition of GINA asthma diagnostic criteria; Subjects must sign informed consent prior to study participation, participate in the study according to the protocol and follow up for 2 years.

Exclusion: Thoracic or abdominal surgery in the past 3 months; Eye surgery in the past three months; Suffering from other massive lung tissue destructive diseases such as severe bronchiectasis and tuberculosis; Severe pleural disease and/or sternal and rib lesions; Serious uncontrolled disease of other system; Myocardial infarction within the last 3 months; Hospitalized for heart disease within the past 3 months; Ongoing anti-tuberculosis treatment; Retina detachment; Pregnancy or breast feeding.

ClinicalTrials.gov NCT05937334